Annual Retained Earnings
-$102.74 M
-$33.78 M-48.97%
30 September 2022
Summary:
NeuBase Therapeutics annual retained earnings is currently -$102.74 million, with the most recent change of -$33.78 million (-48.97%) on 30 September 2022. During the last 3 years, it has fallen by -$33.78 million (-48.97%).NBSE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$116.47 M
-$1.82 M-1.59%
30 September 2023
Summary:
NeuBase Therapeutics quarterly retained earnings is currently -$116.47 million, with the most recent change of -$1.82 million (-1.59%) on 30 September 2023.NBSE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -49.0% | -68.9% |
| 5 y5 years | -292.5% | -345.0% |
NBSE Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | <-9999.0% | <-9999.0% |
NeuBase Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -$116.47 M(+1.6%) |
| June 2023 | - | -$114.65 M(+3.1%) |
| Mar 2023 | - | -$111.21 M(+3.8%) |
| Dec 2022 | - | -$107.11 M(+4.3%) |
| Sept 2022 | -$102.74 M(+49.0%) | -$102.74 M(+8.0%) |
| June 2022 | - | -$95.11 M(+9.8%) |
| Mar 2022 | - | -$86.62 M(+12.9%) |
| Dec 2021 | - | -$76.70 M(+11.2%) |
| Sept 2021 | -$68.97 M(+58.3%) | -$68.97 M(+11.6%) |
| June 2021 | - | -$61.81 M(+16.3%) |
| Mar 2021 | - | -$53.15 M(+11.6%) |
| Dec 2020 | - | -$47.63 M(+9.3%) |
| Sept 2020 | -$43.56 M(+66.4%) | -$43.56 M(+9.8%) |
| June 2020 | - | -$39.68 M(+10.6%) |
| Mar 2020 | - | -$35.88 M(+13.9%) |
| Dec 2019 | - | -$31.51 M(+20.4%) |
| Sept 2019 | -$26.17 M(>+9900.0%) | -$26.17 M(-79.0%) |
| June 2019 | - | -$124.50 M(+0.9%) |
| Mar 2019 | - | -$123.37 M(+0.9%) |
| Dec 2018 | - | -$122.22 M(>+9900.0%) |
| Sept 2018 | -$42.00 K(-100.0%) | -$42.00 K(-100.0%) |
| June 2018 | - | -$114.97 M(+0.5%) |
| Mar 2018 | - | -$114.42 M(+1.9%) |
| Dec 2017 | - | -$112.24 M(+3.8%) |
| Sept 2017 | -$108.09 M(+28.3%) | -$108.09 M(+5.1%) |
| June 2017 | - | -$102.84 M(+3.9%) |
| Mar 2017 | - | -$98.94 M(+8.4%) |
| Dec 2016 | - | -$91.25 M(+8.3%) |
| Sept 2016 | -$84.28 M(+44.0%) | -$84.28 M(+8.5%) |
| June 2016 | - | -$77.64 M(+11.0%) |
| Mar 2016 | - | -$69.94 M(+8.2%) |
| Dec 2015 | - | -$64.66 M(+10.5%) |
| Sept 2015 | -$58.51 M(+35.1%) | -$58.51 M(+7.2%) |
| June 2015 | - | -$54.60 M(+6.5%) |
| Mar 2015 | - | -$51.26 M(+7.0%) |
| Dec 2014 | - | -$47.91 M(+10.6%) |
| Sept 2014 | -$43.31 M(+26.7%) | -$43.31 M(+7.7%) |
| June 2014 | - | -$40.23 M(+86.0%) |
| Mar 2014 | - | -$21.63 M(0.0%) |
| Dec 2013 | - | -$21.63 M(-36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | -$34.18 M(+58.0%) | -$34.18 M(+58.0%) |
| June 2013 | - | -$21.63 M(0.0%) |
| Mar 2013 | - | -$21.63 M(0.0%) |
| Dec 2012 | - | -$21.63 M(0.0%) |
| Sept 2012 | -$21.63 M(-20.1%) | -$21.63 M(-24.4%) |
| June 2012 | - | -$28.60 M(+1.6%) |
| Mar 2012 | - | -$28.14 M(+5.3%) |
| Dec 2011 | - | -$26.72 M(-1.3%) |
| Sept 2011 | -$27.08 M(+25.2%) | -$27.08 M(+5.3%) |
| June 2011 | - | -$25.72 M(+13.9%) |
| Mar 2011 | - | -$22.58 M(+0.7%) |
| Dec 2010 | - | -$22.42 M(+3.7%) |
| Sept 2010 | -$21.63 M(-3.7%) | -$21.63 M(-16.3%) |
| June 2010 | - | -$25.83 M(+0.7%) |
| Mar 2010 | - | -$25.66 M(+13.4%) |
| Dec 2009 | - | -$22.64 M(+0.7%) |
| Sept 2009 | -$22.47 M(+4.0%) | -$22.47 M(+0.6%) |
| June 2009 | - | -$22.34 M(+1.0%) |
| Mar 2009 | - | -$22.11 M(+2.0%) |
| Dec 2008 | - | -$21.67 M(+0.3%) |
| Sept 2008 | -$21.60 M(-0.1%) | -$21.60 M(+1.3%) |
| June 2008 | - | -$21.32 M(-0.1%) |
| Mar 2008 | - | -$21.33 M(+0.4%) |
| Dec 2007 | - | -$21.24 M(-1.8%) |
| Sept 2007 | -$21.63 M(>+9900.0%) | -$21.63 M(+0.9%) |
| June 2007 | - | -$21.44 M(+17.7%) |
| Mar 2007 | - | -$18.21 M(>+9900.0%) |
| Dec 2006 | -$123.70 K(-141.1%) | -$123.70 K(+68.5%) |
| Sept 2006 | - | -$73.40 K(-123.5%) |
| June 2006 | - | $313.00 K(-9.4%) |
| Mar 2006 | - | $345.40 K(+14.7%) |
| Dec 2005 | $301.10 K(-20.6%) | $301.10 K(-39.2%) |
| Sept 2005 | - | $495.60 K(+20.3%) |
| June 2005 | - | $412.10 K(-6.9%) |
| Mar 2005 | - | $442.60 K(+16.7%) |
| Dec 2004 | $379.20 K(+302.5%) | $379.20 K(+25.6%) |
| Sept 2004 | - | $301.80 K(+19.7%) |
| June 2004 | - | $252.10 K(+58.1%) |
| Mar 2004 | - | $159.50 K |
| Dec 2003 | $94.20 K | - |
FAQ
- What is NeuBase Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for NeuBase Therapeutics?
What is NeuBase Therapeutics annual retained earnings?
The current annual retained earnings of NBSE is -$102.74 M
What is the all time high annual retained earnings for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual retained earnings is $379.20 K
What is NeuBase Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NBSE is -$116.47 M
What is the all time high quarterly retained earnings for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly retained earnings is $495.60 K